Initial experiences of switching to faricimab for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population

MLA

Farah N. I. Ibrahim, et al. “Initial Experiences of Switching to Faricimab for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in an Asian Population.” Frontiers in Ophthalmology, vol. 3, Jan. 2024. EBSCOhost, https://doi.org/10.3389/fopht.2023.1346322.

APA

Farah N. I. Ibrahim, Kelvin Y. C. Teo, Tien-En Tan, Hiok Hong Chan, Priya R. Chandrasekaran, Shu-Yen Lee, Anna C. S. Tan, Ranjana Mathur, Choi Mun Chan, Shaun S. Sim, Gavin Siew Wei Tan, Ian Y. S. Yeo, & Chui Ming Gemmy Cheung. (2024). Initial experiences of switching to faricimab for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population. Frontiers in Ophthalmology, 3. https://doi.org/10.3389/fopht.2023.1346322

Chicago

Farah N. I. Ibrahim, Kelvin Y. C. Teo, Tien-En Tan, Hiok Hong Chan, Priya R. Chandrasekaran, Shu-Yen Lee, Anna C. S. Tan, et al. 2024. “Initial Experiences of Switching to Faricimab for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in an Asian Population.” Frontiers in Ophthalmology 3 (January). doi:10.3389/fopht.2023.1346322.